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MYC is a highly pleiotropic transcription factor whose
deregulation promotes cancer. In contrast, we find
that Myc haploinsufficient (Myc+/–) mice exhibit
increased lifespan. They show resistance to several
age-associated pathologies, including osteoporosis,
cardiac fibrosis, and immunosenescence. They also
appear to be more active, with a higher metabolic
rate and healthier lipid metabolism. Transcriptomic
analysis reveals ageneexpressionsignatureenriched
for metabolic and immune processes. The ancestral
role of MYC as a regulator of ribosome biogenesis
is reflected in reduced protein translation, which is
inversely correlated with longevity. We also observe
changes in nutrient and energy sensing pathways,
including reduced serum IGF-1, increased AMPK ac-
tivity, and decreased AKT, TOR, and S6K activities.
In contrast to observations in other longevity models,
Myc+/– mice do not show improvements in stress
management pathways. Our findings indicate that
MYC activity has a significant impact on longevity
and multiple aspects of mammalian healthspan.INTRODUCTION
Myc is a helix-loop-helix leucine zipper transcription factor that is
highly conserved among metazoans (Meyer and Penn, 2008). It
was discovered as the transforming oncogene of theMC29 avian
myelocytomatosis virus and subsequently as the cellular proto-
oncogene activated in Burkitt’s lymphoma. Increased expres-
sion of the MYC protein strongly promotes cell proliferation
and has been documented as a frequent event in a wide variety
of human cancers (Dang, 2012).By interacting with partners such as MAX and ZBTB17 (MIZ1),
MYC can either activate or repress transcription (Meyer and
Penn, 2008). Much effort has been focused on understanding
how MYC influences signaling networks and it has emerged as
a major regulatory hub. In addition to its role in cancer, it is
also critically involved with many essential cellular processes,
and the mouse knockout is embryonic lethal. By conservative
estimates, 15%–20% of all genes are directly regulated
by MYC, including genes that play key roles in metabolism, ribo-
some biogenesis, cell cycle, apoptosis, differentiation, and stem
cell maintenance (Dang, 2012).
While age does not have a significant effect onMyc expression
in any mouse tissue examined (Zahn et al., 2007), many of the
biological processes regulated by MYC have also been impli-
cated in aging and age-associated diseases. MYC upregulates
major biosynthetic pathways leading to cellular growth and pro-
liferation and enhances energy production through glycolysis
and oxidative phosphorylation (Dang, 2012). In contrast, calorie
restriction (CR) and reduction of insulin/IGF-1 signaling promote
longevity (Gems and Partridge, 2013). MYC also increases
protein synthesis by positively regulating ribosome biogenesis
(Brown et al., 2008), while reducing translation can extend life-
span (Johnson et al., 2013).
MYC overexpression results in an increase in reactive oxygen
species (ROS) and DNA damage (Vafa et al., 2002), which are
believed to contribute to the progression of aging (Hoeijmakers,
2009). Stem cell populations decline in number and functionality
with normal aging (Cho et al., 2008; Jang et al., 2011), and
ectopic MYC expression depletes stem cell populations (Eilers
and Eisenman, 2008). MYC may also affect the inflammatory
state that accompanies aging, because it directly regulates
expression of some cytokines (Whitfield and Soucek, 2012)
and may influence the composition of the leukocyte population
via its roles in proliferation and stem cell maintenance (Eilers
and Eisenman, 2008; Wang et al., 2011a).
The overall trend suggested by this evidence is that increased
MYC activity promotes several processes that have beenCell 160, 477–488, January 29, 2015 ª2015 Elsevier Inc. 477
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Figure 1. MYC Expression, Longevity, Body
Mass, and Composition
(A)MYCmRNAandprotein expression.mRNAwas
measured by qRT-PCR. Protein was measured by
immunoblotting of tail fibroblasts or by IF of liver
sections. Fibroblasts: n = 3, 3 months, females.
Liver: n = 3–5, 5–9 months, both sexes.
(B) Survival ofMyc+/+ (blue) andMyc+/– (red) mice.
Each data point shows one animal (N, number of
animals in each cohort).
(C) Lifelong trends of whole body weights. Median
weights (3 week sliding window) of the aging co-
horts in (B). Inset: weights at 500 days and relative
weights of Myc+/– animals.
(D) Relative adiposity. Animals were scanned by
micro-CT imaging. Left: volume of all white fat as
percent of total volume of the animal. Right: vol-
ume of visceral fat as percent of total fat. n = 6,
5 months.
Error bars represent SEM.
See also Figure S1 and Tables S1 and S2.connected with aging and age-associated diseases. To address
the role of Myc in aging, given that a complete loss of Myc
is embryonic lethal while overexpression promotes cancer,
we established a partial loss of function (hypomorphic) model
in the mouse. We previously found that cells knocked out for
one copy of the Myc gene display a variety of mild but distinct
phenotypes, including reduced rates of proliferation (Mateyak
et al., 1997). Similarly, heterozygous (Myc+/–) mice appear
normal and healthy, but have a 20% smaller body mass
(de Alboran et al., 2001; Trumpp et al., 2001). We used this
simple constitutive hypomorphic model to address the conse-
quences of reduced MYC activity on aging.
RESULTS
Experimental Strategy
Mice with all coding exons of one copy of theMyc gene flanked
by LoxP sites (de Alboran et al., 2001) were bred to mice ex-
pressing germline Cre recombinase, converting the floxed allele
to a deletion, and subsequently backcrossed to C57BL/6 for
ten generations. The expected decreases of MYC mRNA and
protein levels in Myc+/– mice were confirmed in tail fibroblasts
and several tissues (Figure 1A and Figures S1A–S1C available
online). MYC chromatin immunoprecipitation of liver extracts
from Myc+/– animals reproducibly gave lower yields, indicating
that in vivo a smaller fraction of DNA was bound by MYC
(Figure S1D).
Myc+/– Mice Have Increased Longevity
Large cohorts of both sexes and genotypes were maintained in a
barrier facility and allowed to die of natural causes. A highly sig-
nificant increase in median lifespan was observed: 10.7% for478 Cell 160, 477–488, January 29, 2015 ª2015 Elsevier Inc.males, 20.9% for females, and 15.1%
for both sexes combined (Figure 1B;
Tables S1 and S2). We do not know the
reason for the greater effect in females;we note, however, that control (Myc+/+) females were shorter
lived than males (Figure S1E), an observation that has been
reported in several colonies of C57BL/6 mice (Ladiges et al.,
2009). Thus, while Myc+/+ males lived 8.8% longer than Myc+/+
females, Myc+/– males and females had equivalent lifespans.
Maximum lifespanswere commensurately increased, with nearly
all of the mice surviving to the longest-lived decile being of
Myc+/– genotype. The instantaneous mortality rate was lower
for Myc+/– mice across all ages (Figure S1F), indicating that the
health benefits are not limited to a particular age.
Myc+/– Mice Are Smaller and Develop and Reproduce
Normally
Myc+/– mice are healthy, robust, and can be group-housed
with theirMyc+/+ littermates without any adverse consequences.
Animals of both sexes are 15%–20% smaller as adults (Fig-
ure 1C). These differences were apparent at weaning and
the weight curves of Myc+/+ and Myc+/– mice were parallel over
time. Mass has been noted as a predictor of longevity in
mice, although this effect is strain-specific (Anisimov et al.,
2004).We found no correlation between longevity and theweight
attained by individual mice within any cohort (Figure S1G).
The decreased size of Myc+/– mice is proportional across all
parts of the body, with the mass ratio of major organs to total
body weight not significantly different between genotypes (Fig-
ure S1H). Prior examination of Myc hypomorphic mice did not
find significant changes in cell size among several organs, which
we confirmed in our animals (Figure S1I). Of particular interest
was adipose tissue, because in several long-livedmousemodels
reduced adiposity has been associated with longevity. Myc+/–
andMyc+/+ mice have a similar proportion of adipose tissue rela-
tive to total body volume and also have similar proportions of
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Figure 2. Metabolic Hormones, Fecundity,
and Cancer Incidence
(A–C) Levels of adiponectin, leptin, and free IGF-1
in plasma. Blood samples were collected after
overnight fasting. n = 5–12, 5 and 22 months,
females.
(D) Lifetime reproductive output. Myc+/– and
Myc+/+ females (n = 5) were bred with Myc+/+
males (left), andMyc+/– andMyc+/+ males (n = 7–9)
were bred with Myc+/+ females (right).
(E) Sexual maturation of females. n = 12–19.
(F) Left: cause of death determined by a veterinary
pathologist. n = 19Myc+/+, 38Myc+/–, both sexes.
Right: incidence of macroscopic cancer noted at
time of autopsy (Myc+/+, 73.4%; Myc+/–, 53.7%;
p = 0.03). n = 64 Myc+/+, 67 Myc+/–, both sexes.
(G) Histopathological analysis was used to deter-
mine the spread (left; number of affected tissues)
and severity (right; maximum grade) of lymphoma.
n = 12 Myc+/+, 27 Myc+/–, both sexes.
Error bars represent SEM.
See also Figure S2 and Table S3.visceral and subcutaneous adipose depots (Figure 1D). Consis-
tent with this, Myc+/– and Myc+/+ mice had similar levels of both
leptin and adiponectin in serum at both 6 and 22 months,
implying similar adipose tissue function (Figures 2A and 2B).
The reduced size ofMyc+/– mice may be due to their lower levels
of serum IGF-1, which we documented in both young and old
animals (Figure 2C).
The concept of a tradeoff between longevity and repro-
duction, namely that increased longevity may bear the cost
of decreased efficacy or duration of reproductive ability, has
been widely discussed. We tested both sexes for reproductive
fitness and longevity and found no significant differences be-
tween the two genotypes (Figures 2D and S2A–S2C). Myc+/–
females displayed slightly accelerated vaginal patency (Fig-
ure 2E), indicating that sexual maturation is not retarded. The
increased longevity of Myc+/– mice is thus not associated with
either slower development or reduced fecundity. We also per-
formed skin wound-healing assays and did not find statistically
significant differences between the genotypes, even in old
animals (Figure S2D).
The Major Cause of Death Is Lymphoma in Both
Genotypes
We performed autopsies on all adequately preserved mice at
time of death and a subset of animals were subjected to a histo-
pathological analysis of 18 tissues. Seventy-nine percent of
Myc+/+ and 81% of Myc+/– mice were deemed to have died of
cancers (of which 80%and 87%, respectively, were lymphomas;
Figure 2F). The spectrum of pathologies was typical of the
C57BL/6 strain of mice and very similar in both genotypes (Table
S3). Hence, the increased longevity of Myc+/– mice is not due to
fewer cancer-caused deaths.Cell 160, 477–488We, however, also noted evidence
for decreased progression of cancer
in Myc+/– animals. First, careful macro-
scopic examination at time of autopsy re-vealed fewer tumors visible to the naked eye (Figure 2F). Second,
histopathological analysis showed that by the time of death lym-
phoma spread to significantly fewer organs (Figure 2G). Third,
while the severity (maximumgrade) of lymphoma at time of death
was similar in both genotypes, Myc+/– mice survived consider-
ably longer. Others have reported that reducing cancer preva-
lence alone does not substantially extend lifespan (Matheu
et al., 2004). Additional data from multiple organ systems pre-
sented below indicate that other effects of the Myc+/– genotype
are likely to contribute to the extended lifespan.
Gene Expression Analysis Points to Changes in
Metabolism, the Immune System, and a Unique
Expression Signature
Microarray expression profiling was performed on liver, skeletal
muscle, and white adipose (gonadal) tissues in 5- and 24-month-
old animals. A principal component analysis showed that the first
component was tissue, the second age, and the third genotype,
representing 61.6%, 30.0%, and 2.9% of the total variability,
respectively (Figure 3A; Table S4). The relatively small effect of
the Myc+/– genotype is notable, accounting for 10-fold fewer
changes than those due to age. For all three tissues, both the
number of differentially expressed genes and magnitude of
average change with age were lower in Myc+/– animals (Fig-
ure 3B). This reduction in the apparent aging of the transcriptome
suggests thatMyc+/– mice are long-lived because of widespread
changes that affect multiple tissues.
Differentially expressed genes were enriched in pathways
related to the immune system and metabolism, especially that
of lipids (Figure S3A). We also evaluated which upstream regula-
tors could explain this pattern of transcription (Table S5). When
sorted by significance for the effect of genotype in old animals,, January 29, 2015 ª2015 Elsevier Inc. 479
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Figure 3. Transcriptome Analysis
(A) Gene expression changes. Three parameters were compared: genotype (Myc+/+,Myc+/–), age (5, 24 months), and tissue (liver, muscle, adipose). Genotype,
age, and tissue comparisons are connected with diagonal, vertical, and horizontal lines, respectively. The number of genes changing expression is shown above
and below each line. Red numbers: genes upregulated in Myc+/+ versus Myc+/– animals (MYC-activated genes); blue numbers: genes upregulated in Myc+/–
versus Myc+/+ animals (MYC-repressed genes). A 1.5-fold cutoff and a FDR threshold of <5% were used. n = 5–8 male animals.
(B) Effect of age on the transcriptome. Left: number of genes whose expression changes with age by more than 50% in either direction; hatched area represents
genes in common between the two genotypes. Right: the median change in expression with age (expressed as %) across all expressed genes.
(C) Meta-analysis. Differentially expressed genes inMyc+/– versusMyc+/+ animals were compared with genes similarly recovered in studies of calorie restriction,
metformin, or resveratrol treatment (Martin-Montalvo et al., 2013; Pearson et al., 2008). Upward arrows indicate genes upregulated in the long-lived condition
(and conversely for downward arrows). Expression in liver of old male mice was compared. Skeletal muscle showed the same trends.
See also Figure S3 and Tables S4, S5, and S6.regulators of lipid metabolism and the immune system were
prominently enriched. Transcription factors that promote lipid
biosynthesis and adipogenic fate were predicted to become
more active with age in tissues in which adipogenesis and lipid
accumulation are considered pathogenic, such as the liver and
skeletal muscle, and less active with age in adipose tissue.
These changes were reversed in old Myc+/– tissues. The effects
of numerous immune system regulators (including interferons,
interleukins, colony stimulating factors and NF-kB) were strongly
predicted to increase with age in all three tissues, and this effect
was predicted to be counteracted in muscle of Myc+/– mice.
Expression of xenobiotic metabolism enzyme (XME) genes in-
creases with age and is further elevated in male mice that are
long-lived due to genetic, pharmacologic, or dietary interven-
tions (female mice express these genes at an elevated and
mostly constant level) (Li et al., 2013). The XME gene expression480 Cell 160, 477–488, January 29, 2015 ª2015 Elsevier Inc.signature in male Myc+/– mice did not resemble the signatures
observed in several mouse longevity models (Table S6). This
analysis is consistent with the results of stress tests performed
in cell culture with tail fibroblasts established from adult Myc+/–
mice (Figure S3D), which did not display increased resistance
to any of the stressors previously shown to be counteracted by
cells from a variety of long-lived mice. We also note that
compared to other longevity models, some of which display
very pronounced changes in XME gene expression, the changes
in our animals were very modest (Table S6).
In a broadermeta-analysis, we compared our gene expression
data sets with those of other lifespan and healthspan extending
interventions: CR and treatments with resveratrol or metformin.
While some of these interventions show considerable overlap
with one another in differentially expressed genes, especially
CR and metformin (Martin-Montalvo et al., 2013), none were
similar to the Myc+/– signature (Figures 3C and S3B). A meta-
analysis based on Gene Ontology (GO) pathways also failed to
indicate substantial overlap (Figure S3C). As before, CR and
metformin showed much greater similarity to each other than
either with Myc+/–. The few universally enriched GO terms,
however, further implicated metabolism and inflammation; for
example, in muscle the only commonly enriched GO term was
immune response, while in liver high density lipoprotein binding
and hormone activity were two of only five enriched GO terms.
Myc+/– Mice Show Evidence of Improved Healthspan in
Multiple Tissues
The pathological effects of aging in several organ systems were
found to be attenuated inMyc+/– mice. Cardiac fibrosis increases
with age and in diabetes and obesity and has been found to be
reduced in several long-lived mouse models (Dai et al., 2009).
Myc+/– mice had less cardiac fibrosis in old age than Myc+/+
animals (Figure 4A). An important component of healthspan in
females is osteoporosis (Syed and Melim, 2011). In Myc+/+
females, both bone volume and trabecular number declined
with age, whereas trabecular spacing increased (Figures 4B
and 4C). Using all these parameters, oldMyc+/– mice were indis-
tinguishable from young Myc+/+ animals, indicating that Myc+/–
females do not develop osteoporosis by 22 months of age.
Musculoskeletal and neurological performance also decline
with age, and the rotarod test is a frequently used measure of
motor coordination that reflects these parameters. Old Myc+/–
mice were able to remain on the rotarod nearly twice as long
as Myc+/+ animals of the same age (Figure 4G), indicating an
attenuation of the effects of aging on motor function.
Lipid metabolism is strongly affected by aging. Hepatic lipid
droplets (LDs) are small membrane-bound organelles that store
fatty acids and cholesterol and regulate triglyceride metabolism
(Fujimoto and Parton, 2011). LD activities occur mainly at their
surface and hence their size rather than aggregate volume is
a relevant measure of functional capacity. We found that while
total hepatic LD area decreased 2-fold in Myc+/+ animals with
age (Figure S4A), average LD size increased by over 3.5-fold
(Figure 4D). In contrast, total LD content in Myc+/– mice did not
change, and LD size increased to a lesser extent. The relative
preservation of LD surface area in Myc+/– animals is also
consistent with increased expression of genes involved in their
biogenesis (Plin2, Cidec, Fitm1).
Another important healthspan parameter of lipidmetabolism is
cholesterol. Cholesterol levels in mouse liver increase with age,
and interventions that promote longevity, such as CR, result in
decreased cholesterol synthesis (Tsuchiya et al., 2004). In our
microarray data sets, the expression of cholesterol biosynthetic
genes increased with age in Myc+/+ mice. In contrast, almost all
genes in this pathway showed lower expression in Myc+/– ani-
mals, which we confirmed by qRT-PCR (Figure 4E; this included
the rate limiting enzyme, Hmgcr, and the master transcriptional
regulator,Srebf2). Furthermore, both esterified and nonesterified
cholesterol was reduced in serum of Myc+/– mice, as well as in
liver, where it is synthesized and stored (Figure 4F).
Immunosenescence results in part from thymic involution as
well as replicative senescence of some T cell populations (Akbar
and Henson, 2011). Because few T cells are produced by thethymus in older animals, the T cell pool is maintained by the
expansion of existing memory T cells, which is greater for cyto-
toxic CD8+ than regulatory CD4+ T cells (Goronzy and Weyand,
2005). Naive T cells do not proliferate. As previously reported,
the ratios of both CD4+ to CD8+ T cells and of naive to memory
T cells declined with age in normal (Myc+/+) mice, but both were
significantly elevated inMyc+/– animals at 24 months of age (Fig-
ures 5B and 5C). We found no effect of genotype on total T cell
levels (Figure 5A), the presence of macrophages in several tis-
sues (Figure S4B), or total white blood cell counts (Figure S4C).
These results indicate thatMyc+/– animals can maintain younger
and presumably healthier proportions of T cell populations.
We next examined age-related changes in the bone marrow
and thymus where T cells develop and mature. In C57BL/6
mice the thymus begins to involute at 10 months of age and
very little remains by 20 months. Thymic mass was slightly
decreased in Myc+/– mice although the rate of involution was
not changed; adiposity and the proportion of senescent cells
were also not affected by genotype (Figures S4D and S4E).
Hence, the younger T cell profiles in Myc+/– animals are unlikely
to be caused by reduced thymic involution.
Hematopoietic stem cells (HSC) differentiate through several
subpopulations: long term HSC (LT-HSC) differentiate into
short termHSC (ST-HSC), which can then differentiate into either
common myeloid progenitors (CMP) or common lymphoid pro-
genitors (CLP). With normal aging, the CLP/CMP ratio decreases
by 3-fold (Cho et al., 2008). Flow cytometry of HSC showed
that 16-month-old Myc+/– mice had a higher CLP/CMP ratio
relative to Myc+/+ animals (Figures 5D and 5E). This is further
evidence for decelerated aging of the hematopoietic system
and might be responsible for the observed changes in T cell pro-
portions. Consistent with this, we found that Myc+/– mice have
a lower ratio of ST-HSC to LT-HSC (Figure 5F), suggesting that
LT-HSC can persist in greater numbers and/or functional
capacity into old age.
Myc+/– Mice Do Not Show Changes in Pathways Linked
to Macromolecular Damage
A commonly invoked cause of aging is the accumulation of
damage to macromolecules, particularly from oxidative stress.
Genotoxic stress, manifested as various forms of DNA damage,
increases dramatically with age (Hoeijmakers, 2009). We exam-
ined the frequency of DNA damage foci, and while we saw clear
evidence of the age-associated increase, theMyc genotype had
no effect (Figure 5G). Genotoxic stress and other forms of dam-
age can lead to apoptosis, which has been found to rise with age
in several tissues (Kujoth et al., 2005). While we observed the
increase with age, the changes were equivalent in Myc+/+ and
Myc+/– mice (Figure 5H). Genotoxic stress is also a major trigger
of cellular senescence. As with apoptosis, however, Myc geno-
type did not affect the age-associated increase in cellular senes-
cence (Figure S4E).
The cyclin-dependent kinase inhibitors p21 (Cdkn1a) and p16
(Cdkn2a) are important regulators of cellular senescence. As ex-
pected, both p21 and p16 were upregulated with aging (Figures
S4F and S4G). The expression of p21, which responds strongly
to DNA damage and ROS, was unaffected by Myc genotype in
five tissues. The response of p16, whose regulation is not wellCell 160, 477–488, January 29, 2015 ª2015 Elsevier Inc. 481
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Figure 4. Amelioration of Age-Associated Phenotypes
(A) Cardiac fibrosis was scored in ventricular cross sections using Masson’s trichrome stain. n = 11–14, 22–24 months, both sexes.
(B) Osteoporosis in females was assessed using micro-CT analysis. n = 3–7, 5 and 22 months.
(C) Trabecular spacing and number were scored by micro-CT, as above.
(D) Liver sections were stained with Oil Red O. n = 6, 5 and 24 months, males.
(E) Gene expression in liver wasmeasured by qRT-PCR. Intermediates in the cholesterol biosynthetic pathway are shown on the left and the corresponding genes
on the right. Data are normalized to Myc+/+ for each comparison. n = 4, 24 months, males.
(F) Total and nonesterified cholesterol in liver extracts and serum. Normalized to Myc+/+. n = 5–6, 24 months, males.
(G) Animals of average weight were chosen for rotarod tests, and their performance was corrected for their weight. n = 3–4, 24 months, males.
Error bars represent SEM.
See also Figure S4.understood, varied between tissues: it was unaffected inMyc+/–
relative toMyc+/+ mice in heart, reduced in liver and spleen, and
increased in lung. F2-isoprostanes, products of lipid peroxida-
tion, are a sensitive and accurate biomarker of oxidative status.482 Cell 160, 477–488, January 29, 2015 ª2015 Elsevier Inc.As expected, we found that levels of F2-isoprostanes rose
with age, but the changes were the same in Myc+/+ and Myc+/–
animals (Figure 5I). Hence, Myc+/– animals do not seem to be
protected from age-associated increases in ROS, or from the
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Figure 5. Immunosenescence, Stress Defenses, and Metabolic Activity
(A) Total T cells (CD3+) were analyzed by flow cytometry as % of total peripheral lymphocytes. n = 8–12, 5 and 24 months, males.
(B and C) Ratio of naive to memory T cells (CD44–/CD44+) (B) and ratio of helper to killer T cells (CD4+/CD8+) (C) were measured in the same samples.
(D) Proportions of common myeloid and lymphoid progenitors (CMP, CLP), and short-term and long-term hematopoietic stem cells (ST-HSC, LT-HSC) were
scored as % of Lin– cells in bone marrow (tibia and femur). n = 6, 16 months, females. Normalized to Myc+/+ for each comparison.
(E and F) Ratio of CLP to CMP (E) and ratio of ST-HSC to LT-HSC (F) in the same samples.
(G) 53BP1-positive cells were visualized by IF in liver sections. n = 5–6, 5 and 25 months, males.
(H) Apoptotic cells in liver were identified by IF with an antibody to cleaved caspase-3. n = 6–8, 5 and 22 months, females.
(I) F2 isoprostane levels were measured in liver extracts using gas chromatography and mass spectrometry. n = 4–7, 5 and 23–27 months, males.
(J) O2 consumption by young animals over a 24 hr period. Statistical significance in was computed using two-way ANOVA (time, genotype). Genotype factor was
significantly different; p < 0.001. n = 8, 5 months, both sexes.
(K) O2 consumption by old animals. P(genotype) < 0.001. n = 7–8, 17–22 months, males.
Error bars represent SEM.
See also Figure S5.
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Figure 6. Spontaneous Activity, Energy
Metabolism, and Signaling Pathways
(A) Spontaneous home cage activity. Of the
four categories of behaviors (micromovements,
sleeping, consumption, and active behaviors),
micromovements and active behaviors were
statistically different. n = 6, 16–18 months, males.
(B) AMP concentrations in extracts of muscle.
n = 5–7, 25–30 months, both sexes.
(C) AMP to ATP ratio in the same samples (B).
(D) The ratio of phosphorylated (Thr172) to total
AMPKa in muscle was determined by immuno-
blotting. Data are normalized to Myc+/+ for each
comparison. n = 4, 9–11 months, females; n = 3,
25–30 months, both sexes.
(E) Ribosomal RNA content of liver. n = 5,
23–25 months, male.
(F) Translation rates in live animals (liver) were
assessed using 3H-phenylalanine incorporation
into total protein. Muscle showed the same trend.
n = 5, 5–7 months; males.
(G) The ratio of phosphorylated (Ser473) to total
AKT in liver andmuscle. n = 4, 9–11months, female
(same samples as in D). Normalized toMyc+/+.
(H) The ratio of phosphorylated (Ser235/236) to
total S6 ribosomal protein in liver and muscle
(same samples as in G. Normalized to Myc+/+.
Error bars represent SEM.
See also Figure S6.consequences of this and other forms of stress, such as DNA
damage, apoptosis, and senescence.
Effects on Metabolic Pathways that Regulate Aging
Metabolic rate, measured by O2 consumption and CO2 produc-
tion, declines during normal aging and is increased by CR and
in the long-lived Ames and GHR-KO dwarf mice (Bartke and
Westbrook, 2012). Interestingly, Myc+/– mice have a signifi-
cantly higher metabolic rate than Myc+/+ animals (Figures 5J,
5K, S5A, and S5B). Although smaller in magnitude, this trend
is already apparent in young Myc+/– mice. Myc+/– animals
also have higher food and water consumption (Figures S5C
and S5D). Animals of both genotypes had equivalent body tem-
peratures (Figure S5E). The higher metabolism of Myc+/– mice
might be needed to thermoregulate their smaller body mass,
which would be expected to predispose to hypothermia. A
small but significant increase in mitochondrial copy number
was found in skeletal muscle (Figure S5F). We also assessed
spontaneous activity using a home-cage monitoring system
based on automated computer analysis of continuous video re-
cordings (Jhuang et al., 2010) and found that 16- to 18-month-
oldMyc+/– mice displayed a higher level of active behaviors and
a lower level of micromovements (Figures 6A and S6A–S6D). Of
the active behaviors, hanging from the wire cage roof was
notable as being almost completely absent in Myc+/+ animals.
The large difference in this high-energy behavior is consistent
with the notably improved rotarod performance (Figure 4G)
and lack of osteoporosis (Figures 4B and 4C) in older Myc+/–
animals.
To further investigate these metabolic changes, we measured
the levels of the major energy metabolites ATP, ADP, and AMP.
We found a small but significant increase in AMP levels and the484 Cell 160, 477–488, January 29, 2015 ª2015 Elsevier Inc.AMP to ATP ratio in muscle of old Myc+/– mice (Figures 6B and
6C), and the same trends were observed in young animals (Fig-
ures S6E and S6F). There was also a trend toward higher ADP
levels (Figure S6G) and similar overall trends in liver (Figures
S6I and S6J). Although small in magnitude, in aggregate these
changes are suggestive of a lower energy status in Myc+/– ani-
mals, a condition known to activate AMP-dependent kinase
(AMPK). In agreement, we observed a significantly higher ratio
of Thr172-phosphorylated AMPKa to total AMPKa (Figure 6D),
indicative of its activation.
MYC is a major regulator of ribosome biogenesis (Brown
et al., 2008). Indeed, analysis of our microarray data suggested
that genes encoding ribosomal proteins are downregulated in
Myc+/– tissues (Figure S6K). We verified this effect by biochem-
ical measurements of rRNA content which showed a small but
significant decrease inMyc+/– mice (Figure 6E). Finally, to directly
query the rate of translation, we measured the in vivo incorpora-
tion of a radioactive amino acid into total protein and also found a
significant decrease in Myc+/– mice (Figure 6F).
Myc+/– mice have reduced levels of circulating IGF-1 (Fig-
ure 2C). To more directly examine signaling through this
pathway, we assessed the activation status of protein kinase B
(AKT). We observed a significantly lower ratio of Ser473-phos-
phorylated AKT to total AKT in liver and muscle of adult Myc+/–
mice (Figure 6G), indicative of reduced activity. Both AMPK
and AKT regulate mTOR and increased AMPK and decreased
AKT activity would promote reduced mTOR activity. We as-
sessed S6 protein kinase activity, a downstream target of
mTOR in the protein translation pathway, by measuring the
phosphorylation state of ribosomal S6 protein. We found a lower
level of phosphorylation in both liver and muscle of adultMyc+/–
mice (Figure 6H).
S6K
Growth
AKT
FOXO
PI3K
RTK
RAS
AMPK
NutrientsIGF-1
Energy
Amino
Acids
Longevity
MYC TOR
Serum IGF-1
HealthspanMYC Mitochondrialuncoupling
Pathological
adipogenesis
Osteoporosis
ImmunosenescenceHSC maintenance
Body mass
Transcriptome 
aging
Musculoskeletal
function
Metabolic rate
Cholesterol
Hepatosteatosis
Cancer
Cardiac fibrosis
This paper Literature
Our data Literature Our data and literature
A  Phenotypes B  Pathways
Biogenesis
Ribosome
Activation
Translation
?
Figure 7. The Effects of Myc on Healthspan and Longevity
(A) Phenotypes of Myc+/– mice demonstrating their interconnectedness and impact on healthspan (the key under the drawing applies to this panel only).
(B) Pathways affected by Myc hypomorphism and their relationship to increased longevity. The components investigated in this report are highlighted in red.DISCUSSION
Myc+/– mice have significantly extended median and maximum
lifespans in both sexes and a reduced mortality rate across
all ages relative to their normal Myc+/+ littermates. Myc haploin-
sufficiency in Drosophila also extends lifespan, pointing to a
deep conservation of the underlying processes (Greer et al.,
2013). Myc+/– mice display ameliorated aging phenotypes
across a variety of pathophysiological processes in multiple
organs, the breadth of which suggests that their increased
longevity is not attributable to the prevention of a specific fatal
disease, but rather to a broadly increased healthspan.
Aging Myc+/– mice have healthier lipid and cholesterol meta-
bolism, stronger bones, less fibrosis, reduced cancer progres-
sion, a higher metabolic rate, improved motor control, and
reduced immunosenescence compared to their normal litter-
mates. All of these phenotypes oppose the effects of normal
aging and are shared with many other long-lived mouse models
(Figure 7; Table S7). For example, CR and Ames dwarf mice also
have an increased metabolic rate (Bartke andWestbrook, 2012);
CR and metformin-treated mice have lower cholesterol (Martin-
Montalvo et al., 2013; Tsuchiya et al., 2004); Ames dwarf, CR and
rapamycin or metformin administration ameliorate cancer (Ikeno
et al., 2003; Martin-Montalvo et al., 2013; Neff et al., 2013); and
CR, Ames dwarf, and metformin-treated mice have better motor
coordination (Brown-Borg et al., 2012; Lanza et al., 2012;Martin-
Montalvo et al., 2013). All of these long-lived models show
reduced body mass. However, Myc hypomorphic mice also
exhibit contrasting phenotypes; for example, rapamycin admin-
istration increases serum cholesterol and does not improve
motor coordination (Neff et al., 2013), Ames dwarf mice have
decreased bone density (Heiman et al., 2003), and CR reduces
fecundity (Lee and Longo, 2011). Compared to most other
longevity extending interventions, many of which compromisesome aspects of healthy physiology, we have to date not found
significant physiological deficits in Myc+/– mice.
How can MYC coordinate these effects? It took several de-
cades of work to elucidate the complex spectrum of genes regu-
latedby this transcription factor. In addition to directly binding the
promoters of its target genes and upregulating them, MYC also
exerts strong secondary effects. For example, it can upregulate
the expression of other transcription factors, such as TFAM
(Gomes et al., 2013). It can modulate gene expression elicited
by other factors, such as ZBTB17 (MIZ1) by directly binding to
them (Herkert and Eilers, 2010), or by displacing some factors,
such as FOXO3A from their promoters (Peck et al., 2013). Finally,
MYC regulates a considerable number of microRNA (miRNA)
genes,withwidespread effects ongene expression (Dang, 2012).
Many MYC targets, direct or indirect, are involved in anabolic
and energy producing processes, and their upregulation is
believed to be the major mechanism by which MYC promotes
cancer (Dang, 2012). The largest category of genes directly up-
regulated by MYC are involved in protein translation, and regula-
tion of the ribosome biogenesis (RiBi) regulon is believed to be
the core and most ancient function of MYC, extending back to
primitive holozoans, the first appearance of the MYC-MAX com-
plex in evolution (Brown et al., 2008). We found that the expres-
sion of Rpl and Rps genes was coordinately reduced in Myc+/–
tissues. In addition, levels of mature rRNA and in vivo translation
rates were decreased. Reducing translation, by a variety of
means and in multiple species, is well known to extend lifespan.
For example (among many others), yeast and nematodes with
mutated ribosomal protein genes, Drosophila overexpressing
TSC1 or TSC2, and mice fed rapamycin or mutated in S6 kinase
1 are all long-lived (Johnson et al., 2013). Given the major and
direct role of MYC on RiBi regulon expression, it is likely that at
least part of the longevity of Myc+/– mice can be attributed to
effects on translation.Cell 160, 477–488, January 29, 2015 ª2015 Elsevier Inc. 485
TOR is a central hub in the networks that sense nutrients and
energy status, and MYC plays a key downstream role in these
pathways (Figure 7). For example, in Drosophila MYC was re-
ported to mediate the protein biosynthetic capacity in response
to insulin signaling (Teleman et al., 2008). Both TOR andMYC are
activated by receptor tyrosine kinase signaling, through PI3K,
RAS, and AKT, with TOR providing an acute response by
posttranslationally regulating its targets and MYC enabling a
long-term response though transcriptional regulation. Given
the downstream position of MYC, it is remarkable that Myc+/–
mice display changes throughout this nutrient and energy
sensing network, all of which have been documented to promote
longevity: increased AMPK activity, decreased AKT and S6K ac-
tivities, and even reduced circulating levels of IGF-1. None of the
genes encoding components of these pathways (including IGF-1
binding proteins) are regulated by MYC in our expression data
sets. AMPK is likely to be regulated secondarily by the reduced
energy status elicited by the higher metabolic rate and activity of
Myc+/– animals. Increased AMPK activity would then result in
reduced TOR and S6K activities. The PI3K and TOR pathways
also contain feedback loops that can be affected by MYC,
for example, acute deletion of Myc was found to impair TOR
signaling during T cell activation (Wang et al., 2011b).
Considering the major longevity models, no set of phenotypes
or pathways emerges as a unifying correlation. In other words,
extended lifespan can be achieved by amelioration of some
age-associated pathophysiologies even if others are left intact.
Aging is increasingly being viewed as a segmental process
(Wu et al., 2013), and the phenotypes of Myc hypomorphic ani-
mals are consistent with this notion. In agreement, a meta-anal-
ysis of gene expression showed limited overlap betweenMyc+/–
mice and CR, metformin, or resveratrol. The same analysis
readily revealed previously reported connections between CR
and metformin treatment (Martin-Montalvo et al., 2013) and
underscores the apparently unique nature of the Myc-elicited
lifespan extension.
How can this observation be reconciled with the prominent
position of MYC in nutrient sensing pathways? First, while
MYC and TOR are both major regulatory hubs, their downstream
outputs are only partially overlapping. For example, while TOR
activity opposes autophagy (Johnson et al., 2013), MYC upregu-
lates it (Dey et al., 2013). Second, we have not detected signifi-
cant changes in stress levels, stress management pathways,
or stress responses in Myc+/– animals. These differences re-
sulted in the low overlap scores returned by the meta-analysis,
although these methods clearly detected commonalities in path-
ways related to metabolism and the immune system.
Production of ROS is well known to increase with age.
Although manipulation of these pathways has not yet achieved
robust lifespan extension in mammals (Salmon et al., 2010), a
stress resistance signature is a component of several important
longevity models (CR, reduced somatotrophic signaling, metfor-
min treatment; Table S7). The XMEpathway, which promotes the
removal of ingested or endogenous toxic metabolites, has been
strongly linked with longevity in invertebrate models (Gems and
Partridge, 2013) and to a more limited extent in the mouse (Li
et al., 2013). Although the expression of some XME genes in liver
increased less with age in male Myc+/– than Myc+/+ mice, this486 Cell 160, 477–488, January 29, 2015 ª2015 Elsevier Inc.effect was of much smaller magnitude than in other long-lived
models. Furthermore, fibroblasts from Myc+/– mice did not
display increased resistance to a variety of chemical stressors.
We looked for changes in the production of ROS (F2 isopros-
tanes), as well as some notable consequences of stress expo-
sure (DNAdouble strand breaks, apoptosis, cellular senescence,
p21 and p16 induction). Although we observed the expected
age-associated increases, we did not observe any significant
or consistent effects of theMyc+/– genotype. In aggregate, these
results indicate thatMyc+/–mice can achieve impressive gains in
longevity without significant improvements in the efficacy of
stress management pathways.
Although it is possible that the phenotypes ofMyc+/–mice pre-
dominantly originate from one cell type or tissue and are medi-
ated in an endocrine manner, given the diverse and widespread
nature of these effects we think this is unlikely. Furthermore, cell-
autonomous effects are clearly apparent in cell culture. As floxed
Myc alleles are available (de Alboran et al., 2001; Trumpp et al.,
2001), investigating the effects of tissue-specific reduction
of MYC activity would be of considerable interest. Similarly,
the relationship between lifespan and healthspan benefits and
the level of MYC activity is not known. We tested a heterozygous
(Myc+/–) condition that resulted in 50% levels of MYC mRNA
and protein. Given thatMyc hypomorphs down to25%expres-
sion are viable, it would be interesting to ask whether these
animals continue to accrue healthspan benefits.
A general theme emerging from aging studies in multiple spe-
cies is that ‘‘less is better’’: less food, less somatotrophic/IGF-1
signaling, less anabolic activity, less protein translation, etc., and
MYC certainly fits well in this paradigm. The majority of genes
studied for their promotion of longevity act in signaling pathways.
MYC, as a transcription factor, stands out because of the vast
size of its regulome. The Myc gene is strongly upregulated by
mitogens, and by virtue of its widespread targets constitutes
the ‘‘gas pedal’’ that allows a cell to double its mass every
18–24 hr. It is thus not surprising that MYC is necessary
during embryonic development, and its deregulated expression
strongly promotes cancer. Our discovery that long-term reduc-
tion of MYC activity robustly extends lifespan greatly extends
our understanding of the biology regulated by this fascinating
gene. Given the variety of other physiological benefits, further
studies of MYC and its targets should be an interesting avenue
to explore in human medicine.
EXPERIMENTAL PROCEDURES
Use and Treatment of Animals
Mice were produced and housed in a specific pathogen-free Association for
Assessment and Accreditation of Laboratory Animal Care (AAALAC)-certified
barrier facility. All procedures were approved by the Brown University Institu-
tional Animal Care and Use Committees (IACUC) committee. For longevity
studies animals, were allowed to die naturally. Both females and males in
the longevity study were virgins. Animals of both genotypes and the same
sex were housed together.
Statistical and Demographic Analysis
Data are shown as means with SEM (unless stated otherwise). N indicates
the number of animals per test group; age and sex are also noted. Student’s
t test (unpaired, two-tailed, equal variance) was used for all pairwise compar-
isons. All relevant p values are shown in the figures; if not shown, the values
were >0.05. Demographic data were processed with JMP software to
compute mean and median lifespans, SEM, percent increase of the median,
and p values (log-rank test) for each cohort. Mortality rate was calculated as
log (-log [survival]). Maximum lifespans were calculated as the proportion of
each cohort still alive when the total population reached 90% mortality, using
Fisher’s exact test to determine statistical significance.
Procedures Performed on Live Animals
To score vaginal patency, mice were examined daily from weaning until
vaginal opening was observed. Reproductive longevity and output of males
were determined by continuously housing young males of either genotype
with Myc+/+ females until pregnancies ceased. Females were replaced every
6 months. For female fecundity, young females of either genotype were
continuously mated with one Myc+/+ male. For rotarod tests the apparatus
(MedAssociates) was accelerated continuously from 4 to 40 revolutions per
min. O2 consumption, CO2 production, food, and water intake were measured
using the comprehensive lab animal monitoring system (CLAMS, Oxymax
Open Circuit Calorimeter, Columbus Instruments). Spontaneous home cage
activity was monitored using fully automated computer vision analysis of
continuous video recordings. Wound-healing experiments were performed
by introducing one 6 mm diameter full thickness skin punch on the back
between the shoulder blades.
Histological Analysis
Mice were euthanized in the morning (8–10 a.m.) by isoflurane anesthesia fol-
lowed by cervical dislocation. The dissection was performed rapidly (<3 min)
by several trained staff members working in concert on one mouse. Paraffin-
embedded specimens were stained with H&E. OCT-embedded specimens
were used for the determination of fibrosis (Masson’s trichrome stain), lipid
content (Oil Red O stain), and cellular senescence (senescence-associated
b-galactosidase stain). Immunofluorescencemicroscopy was used to quantify
MYC protein, cleaved caspase-3, 53BP1 foci, and macrophages.
Analytical Procedures
Individual gene expression was measured by qRT-PCR (SYBR Green system,
ABI 7900 Fast Sequence Detection instrument). Total RNA was extracted from
cells or tissue samples (20–50 mg, stored at 80C) with Trizol reagent (Invi-
trogen), purified using the RNeasy Mini kit (QIAGEN), and reverse transcribed
using the TaqMan kit (Applied Biosystems). Expression profiling was per-
formed using Mouse 1.0 Gene ST arrays (Affymetrix), and analyzed using
Expression Console software (Affymetrix) and Ingenuity Pathway Analysis
software (Ingenuity Systems). rRNA was purified by affinity capture using the
RiboMinus kit (Life Technologies). Chromatin immunoprecipitation was per-
formed with the Magna ChIP kit (Millipore) on nuclei isolated from intact frozen
liver tissue. Immunoblotting of proteins was performed using SDS-PAGE of
whole cell extracts, electro-transfer onto Immobilon-P membranes (Millipore),
and staining with the indicated antibodies. Signals were detected using the LI-
COR Odyssey (LI-COR Biosciences) infrared imaging system. Bone density
and adipose tissue were assessed using a Scanco Medical Micro-CT 40
instrument on whole animals immediately after euthanasia. Lipids were ex-
tracted using the Folch method and cholesterol was measured with the
Amplex Red Cholesterol kit (Invitrogen). F2 isoprostane levels were measured
using gas chromatography and mass spectrometry. Leptin and adiponectin
were quantified in plasma using the Luminex magnetic bead platform (Milli-
pore) with the mouse adipokine panel and the adiponectin single-plex assay.
Free IGF-1 in plasma was measured with an ELISA kit from Abcam. Lymphoid
and myeloid cells in blood or bone marrow were quantified by flow cytometry.
Blood was harvested by cardiac puncture into heparinized tubes, cells were
collected by centrifugation, and erythrocytes were lysed with FACS lysing
solution (Becton Dickinson). Bone marrow was flushed out of the femur and
tibia. In both cases the cell suspensions were stained with the indicated fluo-
rescently conjugated antibodies and analyzed using a Becton Dickinson
FACSAria instrument. To measure AMP, ADP, and ATP, frozen tissue speci-
mens were homogenized (Fisher Scientific, PowerGen Model 125), extracted
in perchloric acid, and neutralized with K2CO3 on ice. Ion-paired HPLC was
run on an Agilent 1200 series instrument using a ZORBAX Eclipse XDB-C18
column (Agilent). To assess protein translation in live animals, L-3H-phenylal-anine (Perkin-Elmer, 100–140 Ci/mmol) was combined with unlabeled
phenylalanine (135 mM), and injected at 1 ml/100 g body weight into the tail
vein. Animals were kept under anesthesia for the entire duration (0–30 min),
sacrificed by cervical dislocation, and tissues were snap frozen in liquid nitro-
gen. Incorporation of 3H-phenylalanine was measured by TCA precipitation of
total protein and scintillation counting. Detailed protocols are provided in the
Supplemental Information.
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